MHRA seeks views on reclassification of Nuromol (ibuprofen and paracetamol) to GSL

The public has until 3rd June to respond to the consultation on the potential reclassification of Nuromol, used for the temporary relief of mild to moderate pain, to a general sale list medicine. If reclassified it will be available in a pack of 6 tablets.

Source:

Medicines and Healthcare products Regulatory Agency